Canndoc

What Canndoc does

Canndoc Ltd. develops and supplies GMP pharma-grade medical cannabis products from its headquarters in Herzliya, Israel, operating as a wholly-owned subsidiary of InterCure Ltd. (NASDAQ: INCR; TASE: INCR). Founded in 2008 by Avner Neri Barak and active for more than 15 years, the company sells a portfolio of cannabis oils (in balanced, THC-dominant, and CBD-dominant formulations up to T20/C4 and a pure CBD isolate T0/C24) and dried-flower inflorescences, all manufactured to pharmaceutical Good Manufacturing Practice standards and meeting European, Canadian, and Israeli regulatory requirements. Its underlying technology stack rests on a proprietary genetic bank of 30+ unique cannabinoid profiles, full-spectrum oil extraction methods that preserve the original strain profile, and a proprietary clinical database covering 40,000+ patients and 500,000+ doses, which underpins a 10-trial clinical program across adult epilepsy, fibromyalgia, neuropathic pain, chemotherapy side effects, Parkinson's, rheumatoid arthritis, PTSD, and lumbar radiculopathy.

The company serves three end markets in parallel. In Israel it distributes through long-term pharmacy partnerships with Super-Pharm (the country's leading pharmacy chain), the Givol pharmacy chain, and S.L.E (a Teva subsidiary) under a physician-prescription model that targets patients with neuropathic pain, cancer pain, inflammatory bowel disease, PTSD, Parkinson's, epilepsy, multiple sclerosis, chemotherapy side effects, and related conditions. Internationally, Canndoc runs export-import agreements with Tilray, Aphria, and Organigram and an expanding portfolio of brand licenses (Cookies for Europe, Binske globally, TYSON 2.0 across Israel/Australia/UK/Germany/EU, plus Charlotte's Web, Humboldt, KOOTS CANNA, TOTEM, PurpleFarm, Space Labs, CRAFT, and Diamonds/Fotmer), enabling cross-border trade and market entry behind established consumer brands. Revenue mechanics are predominantly physical-product sales (oils and inflorescences) distributed through pharmacy channels in Israel and through wholesale supply agreements to large Canadian producers and licensed brand partners abroad; pricing is prescription-driven and not publicly disclosed.

Name

Canndoc

Legal name

Canndoc Ltd.

Website

https://canndoc.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

51–100 employees

Short description

Canndoc is an Israel-based, GMP-certified producer of pharma-grade medical cannabis oils and inflorescences, serving 40,000+ Israeli patients via pharmacy networks (Super-Pharm, Givol, S.L.E/Teva) and international wholesale partners including Tilray, Organigram, and Aphria. It is a wholly-owned subsidiary of Nasdaq-listed InterCure Ltd.

Ownership category

akta.pro rank

Product category

Pharmaceutical Medical Cannabis

NAICS

Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)

akta.pro secondary industry

Cannabis Dispensary + Ancillary Retail (Accessories, CBD/Hemp, Merchandise) (CRANAFAH)

Keywords

• Medical cannabis production
• GMP pharmaceutical manufacturing
• Cannabis oil products
• Medical cannabis distribution
• Cannabinoid therapy

Headquarters

HQ city

Herzliya

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Others

Revenue model

1. Medical Cannabis Product Sales: Production and sale of GMP-grade medical cannabis products including oils and inflorescences (dried flowers) with various THC/CBD ratios prescribed for conditions such as neuropathic pain, cancer pain, inflammatory bowel disease, PTSD, Parkinson's, and epilepsy
2. International Trade and Export: International trade of medical cannabis products including import-export agreements with companies like Tilray, Organigram, and Aphria for cross-border distribution

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Canndoc produces and distributes GMP pharma-grade medical cannabis products, including a portfolio of cannabis oils in various THC/CBD ratios (balanced, THC-dominant, CBD-dominant, and pure CBD isolate) and dried flower inflorescences. Products are manufactured to pharmaceutical-grade standards and prescribed for conditions including neuropathic pain, cancer pain, epilepsy, PTSD, Parkinson's, inflammatory bowel disease, multiple sclerosis, and chemotherapy side effects. The company also operates brand partnerships distributing international cannabis brands through its pharmacy and international partner network.

Product overview

Canndoc is a GMP (Good Manufacturing Practice) pharma-grade medical cannabis company offering a comprehensive portfolio of pharmaceutical-quality cannabis products. The core product lines include cannabis oils (in various THC/CBD ratios from balanced to THC-dominant and CBD-dominant formulations including pure CBD isolate) and dried flower inflorescences. The company also operates multiple licensed brand partnerships including KOOTS CANNA, TOTEM, Binske, Cookies, Humboldt, Space Labs, CRAFT, PurpleFarm, Stars, and Diamonds (Fotmer), along with proprietary sub-brands like Canndoc BLACK, Canndoc TRP, and Shapes. Products cover regulatory requirements for European, Canadian, and Israeli markets, with varieties ranging from T0/C24 (pure CBD) to T20/C4 (high THC), prescribed for conditions including neuropathic pain, epilepsy, inflammatory bowel disease, PTSD, Parkinson's, and cancer-related symptoms. The company serves patients through pharmacy networks including Super-Pharm/Giv'ol and operates international partnerships for supply and distribution.

Differentiator

Problem solved

Functional benefit

Brands

• Canndoc Diamonds: Premium cannabis product line featuring strains like Gorilla Glue and Mango in full spectrum oil format
• Canndoc TRP
• Canndoc BLACK
• Canndoc Cali
• Canndoc Indoor Premium Craft
• PURAKA
• NAVAJO
• COYA

Products and services

• GMP Medical Cannabis Oils

Quantifiable outcome

• Served 40,000+ patients with millions of doses
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• TYSON 2.0coreGTM or Marketing Partner · 20 April 2023InterCure Ltd. partnered with TYSON 2.0 for distribution in Israel, Australia, United Kingdom, Germany and other EU countries.
• BinskecoreGTM or Marketing Partner · 19 December 2022InterCure announced exclusive international partnership agreement with award-winning cannabis brand Binske for global market distribution.
• CookiescoreGTM or Marketing Partner · 6 April 2021InterCure announced agreement with Cookies to expand the iconic cannabis brand across Europe, leveraging Cookies' strong brand recognition.
• Fotmer Life SciencesminorChannel Partner/ Reseller/ Distributor · 22 December 2020Uruguayan cannabis company Fotmer Life Sciences signed a supply agreement to provide cannabis products to Canndoc, expanding supply chain sources.
• Charlotte's WebminorStrategic or Co-development Partner · 9 December 2020Charlotte's Web expanded into Israel through strategic alliance with InterCure (owner of Canndoc), bringing CBD products to the Israeli market.
• OrganigramcoreStrategic or Co-development Partner · 14 August 2020Organigram sent first shipment of indoor-grown dried flower to Canndoc as part of an international strategic agreement representing the largest such deal to date for international cannabis trade.
• Super-PharmcoreChannel Partner/ Reseller/ Distributor · 4 March 2020Long-term partnership agreement for distribution of GMP medical cannabis products through Super-Pharm's pharmacy network across Israel.
• AphriacoreStrategic or Co-development Partner · 4 March 2020Aphria Inc., a leading Canadian cannabis company, signed a strategic supply agreement with Canndoc for international product supply.
• TilraycoreStrategic or Co-development Partner · 2 January 2020Canndoc signed a cannabis import-export deal with Tilray, a leading Canadian cannabis company. This partnership resulted in Israel's first imported medical cannabis shipment, enabling cross-border trade and access to international cannabis products for the Israeli market.
• S.L.E (Teva)coreChannel Partner/ Reseller/ Distributor · 12 September 2019S.L.E (a subsidiary of Teva Pharmaceuticals) signed a deal to distribute Canndoc's GMP-approved products to pharmaceutical customers in Israel.

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Organigram Holdings: Canadian licensed producer that signed one of Canndoc's largest international supply agreements. Compares as a multi-country medical cannabis producer serving European and Israeli channels.
• Charlotte's Web Holdings: CBD-focused cannabis wellness company that entered Israel through a strategic alliance with InterCure (Canndoc's parent). Comparable in standardized botanical cannabis products serving medical patients.
• Bol Pharma: Israeli medical cannabis cultivator and producer operating in the same regulatory environment and pharmacy distribution model as Canndoc. Directly comparable as a domestic Israeli GMP-certified competitor.
• Panaxia Pharmaceutical Industries: Israeli pharma-grade medical cannabis producer with similar GMP manufacturing standards and pharmacy-channel distribution. Closest direct domestic competitor to Canndoc in the Israeli market.
• Cookies Enterprises: Iconic US cannabis lifestyle brand partnered with InterCure/Canndoc to expand across Europe. Comparable as a premium cannabis brand leveraging Canndoc's international distribution platform.
• Tilray Brands: Global medical and adult-use cannabis producer with which Canndoc has an active import-export partnership. Directly comparable as a GMP-certified international medical cannabis producer serving pharmacy channels.

Emerging players

• Binske: Award-winning premium cannabis brand holding an exclusive international distribution partnership with InterCure/Canndoc. Comparable as a craft/lifestyle cannabis brand commercialized through Canndoc's platform.

Broad incumbents

• Canopy Growth Corporation: One of the largest Canadian cannabis producers with global medical and consumer brands. Overlaps with Canndoc in pharmaceutical-grade medical cannabis production and international distribution.
• Aurora Cannabis: Large Canadian licensed producer with established EU and international medical cannabis distribution. Comparable to Canndoc as a multi-jurisdictional GMP-certified producer, though operating at much larger scale.

Regional players

• Fotmer Life Sciences: Uruguayan organic cannabis producer with a supply agreement into Canndoc. Comparable as a Latin American GMP-grade producer accessing the Israeli/European market through Canndoc.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/canndoc
• Instagraminstagram.com/canndoc
• LinkedInlinkedin.com/company/canndoc

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canndoc